Evidence map›Paper›PMID 27159577›Full record

ArticleNature chemical biology2016

Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis.

Kenichi Shimada, Rachid Skouta, Anna Kaplan, Wan Seok Yang, Miki Hayano, Scott J Dixon, Lewis M Brown, Carlos A Valenzuela, Adam J Wolpaw, Brent R Stockwell

Abstract read
In one paragraph

Article in Nature chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 643 papers.

0numbers the graph read from it
0cells of the map it votes in
643citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

643 citing papers in PubMed, 963 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Ferroptosis in liver biology and diseases.Hepatology communications · 2026
    Review
  8. Ferroptosis as a target mechanism in heart and kidney disease.The Journal of clinical investigation · 2026
    Review
  9. Article
  10. The Emerging Role of Ferroptosis in Pediatric Cancer Biology and Therapy.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. CD8Reproductive sciences (Thousand Oaks, Calif.) · 2026
    Article
  19. Review
  20. Review

583 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kenichi ShimadaDepartment of Biological Sciences, Columbia University, New York, New York, USA.ORCID 0000-0001-8540-9785
Rachid SkoutaDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Anna KaplanDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Wan Seok YangDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Miki HayanoDepartment of Pharmacology, Columbia University, New York, New York, USA.
Scott J DixonDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Lewis M BrownQuantitative Proteomics Center, Columbia University, New York, New York, USA.
Carlos A ValenzuelaDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Adam J WolpawDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Brent R StockwellDepartment of Biological Sciences, Columbia University, New York, New York, USA.ORCID 0000-0002-3532-3868
Columbia University · USChildren's Hospital of Philadelphia · US

Funding

Defining the functions and translational potential of ferroptosisR35CA209896 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2016 to 2022
$6.5M
Chemical Genetic Profiling of Engineered Tumor CellsR01CA097061 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI STOCKWELL, BRENT R. · 2002 to 2016
$4.8M
Using Components of the Circadian Clock to Regulate Stem Cell Fate DecisionsDP2OD006740 · OD · STANFORD UNIVERSITY · PI FELDMAN, BRIAN J · 2010 to 2010
$2.4M
Integrated Systemic and Adipose Depot-Specific Regulation of AdipogenesisR01DK114217 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FELDMAN, BRIAN J · 2017 to 2021
$2.1M
Defining a novel trigger for apoptosisR01GM085081 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2008 to 2011
$1.5M
Comparing HTS with Fragment-Based Design for B-Raf and the Ras-Raf InteractionR01CA161061 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2011 to 2014
$1.0M
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell DeathR00CA166517 · NCI · STANFORD UNIVERSITY · PI DIXON, SCOTT · 2014 to 2016
$708k
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell DeathK99CA166517 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DIXON, SCOTT · 2012 to 2013
$250k
NCI NIH HHS K99 CA166517NCI NIH HHS R00 CA166517NCI NIH HHS R01 CA097061NCI NIH HHS R01 CA161061NCI NIH HHS R35 CA209896NIDDK NIH HHS R01 DK114217NIGMS NIH HHS R01 GM085081NIH HHS DP2 OD006740
6 · The paper itself

Abstract

Apoptosis is one type of programmed cell death. Increasingly, non-apoptotic cell death is recognized as being genetically controlled, or 'regulated'. However, the full extent and diversity of alternative cell death mechanisms remain uncharted. Here we surveyed the landscape of pharmacologically accessible cell death mechanisms. In an examination of 56 caspase-independent lethal compounds, modulatory profiling showed that 10 compounds induced three different types of regulated non-apoptotic cell death. Optimization of one of those ten resulted in the discovery of FIN56, a specific inducer of ferroptosis. Ferroptosis has been found to occur when the lipid-repair enzyme GPX4 is inhibited. FIN56 promoted degradation of GPX4. FIN56 also bound to and activated squalene synthase, an enzyme involved in isoprenoid biosynthesis, independent of GPX4 degradation. These discoveries show that dysregulation of lipid metabolism is associated with ferroptosis. This systematic approach is a means to discover and characterize novel cell death phenotypes.

Indexed as

ApoptosisDose-Response Relationship, DrugHumansIronLipid MetabolismOximesStructure-Activity RelationshipSulfonamidesFIN56 compoundIronOximesSulfonamides

Identifiers

PMID27159577
PMCPMC4920070
OpenAlexW2345350059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.